Developments in preclinical cancer imaging: innovating the discovery of therapeutics
JRW Conway, NO Carragher, P Timpson - Nature reviews cancer, 2014 - nature.com
Integrating biological imaging into early stages of the drug discovery process can provide
invaluable readouts of drug activity within complex disease settings, such as cancer …
invaluable readouts of drug activity within complex disease settings, such as cancer …
Fluorescence anisotropy (polarization): from drug screening to precision medicine
H Zhang, Q Wu, MY Berezin - Expert opinion on drug discovery, 2015 - Taylor & Francis
Introduction: Fluorescence anisotropy (FA) is one of the major established methods
accepted by industry and regulatory agencies for understanding the mechanisms of drug …
accepted by industry and regulatory agencies for understanding the mechanisms of drug …
Global profiling of co- and post-translationally N-myristoylated proteomes in human cells
Protein N-myristoylation is a ubiquitous co-and post-translational modification that has been
implicated in the development and progression of a range of human diseases. Here, we …
implicated in the development and progression of a range of human diseases. Here, we …
Rapid global fitting of large fluorescence lifetime imaging microscopy datasets
Fluorescence lifetime imaging (FLIM) is widely applied to obtain quantitative information
from fluorescence signals, particularly using Förster Resonant Energy Transfer (FRET) …
from fluorescence signals, particularly using Förster Resonant Energy Transfer (FRET) …
Screening for protein-protein interactions using Förster resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM)
A Margineanu, JJ Chan, DJ Kelly, SC Warren… - Scientific reports, 2016 - nature.com
We present a high content multiwell plate cell-based assay approach to quantify protein
interactions directly in cells using Förster resonance energy transfer (FRET) read out by …
interactions directly in cells using Förster resonance energy transfer (FRET) read out by …
SUMOylation inhibits FOXM1 activity and delays mitotic transition
SS Myatt, M Kongsema, CWY Man, DJ Kelly… - Oncogene, 2014 - nature.com
The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase
transition, mitosis and the DNA damage response. As such, it is frequently deregulated …
transition, mitosis and the DNA damage response. As such, it is frequently deregulated …
FLIM-FRET for cancer applications
Optical imaging assays, especially fluorescence molecular assays, are minimally invasive if
not completely noninvasive, and thus an ideal technique to be applied to live specimens …
not completely noninvasive, and thus an ideal technique to be applied to live specimens …
High-throughput, multi-parametric, and correlative fluorescence lifetime imaging
In this review, we discuss methods and advancements in fluorescence lifetime imaging
microscopy that permit measurements to be performed at faster speed and higher resolution …
microscopy that permit measurements to be performed at faster speed and higher resolution …
Fast Fluorescence Lifetime Imaging Reveals the Aggregation Processes of α-Synuclein and Polyglutamine in Aging Caenorhabditis elegans
The nematode worm Caenorhabditis elegans has emerged as an important model organism
in the study of the molecular mechanisms of protein misfolding diseases associated with …
in the study of the molecular mechanisms of protein misfolding diseases associated with …
Mouse Stbd1 is N-myristoylated and affects ER–mitochondria association and mitochondrial morphology
A Demetriadou, J Morales-Sanfrutos… - Journal of cell …, 2017 - journals.biologists.com
Starch binding domain-containing protein 1 (Stbd1) is a carbohydrate-binding protein that
has been proposed to be a selective autophagy receptor for glycogen. Here, we show that …
has been proposed to be a selective autophagy receptor for glycogen. Here, we show that …